AIM IMMUNOTECH INC.

Profile

Company Names

AIM IMMUNOTECH INC.
HEMISPHERX BIOPHARMA INC

Addresses

2117 SW HIGHWAY 484, OCALA, FL 32801

860 N. ORANGE AVENUE, SUITE B, ORLANDO, FL 32801

1617 JFK BLVD, SUITE #500, ONE PENN CENTER, PHILADELPHIA, PA 19103

Phone Numbers

352-448-7797
215-988-0080

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$3,378,506.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-02-16 
$3,301,250.00 
$3,301,250.00 
$0.00 
Debt 
3
2018-04-24 
$25,740.00 
$25,740.00 
$0.00 
 
2
2017-02-03 
$18,182.00 
$18,182.00 
$0.00 
 
1
2016-08-30 
$33,334.00 
$33,334.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEWART 
 
APPELROUTH 
DIRECTOR
HEMISPHERX BIOPHARMA INC   |  AIM IMMUNOTECH INC.
NANCY 
 
BRYAN 
DIRECTOR
AIM IMMUNOTECH INC.
ROB 
 
DICKEY 
EXECUTIVE OFFICER
AIM IMMUNOTECH INC.
THOMAS 
 
EQUALS 
EXECUTIVE OFFICER, DIRECTOR
AIM IMMUNOTECH INC.
THOMAS 
K 
EQUELS 
EXECUTIVE OFFICER, DIRECTOR
HEMISPHERX BIOPHARMA INC
WILLIAM 
 
MITCHELL 
DIRECTOR
LAUNCHCYTE LLC   |  CHRONIX BIOMEDICAL INC   |  SYNQY CORP   |  PICOBREW, INC.   |  7MB TECHNOLOGIES CORP   |  CRYSTALPLEX CORP   |  HEMISPHERX BIOPHARMA INC   |  AIM IMMUNOTECH INC.   |  EXPERIC, LLC
ADAM 
 
PASCALE 
EXECUTIVE OFFICER
HEMISPHERX BIOPHARMA INC
PETER 
 
RODINO 
EXECUTIVE OFFICER
AIM IMMUNOTECH INC.
PETER 
W 
RODINO 
DIRECTOR, EXECUTIVE OFFICER
HEMISPHERX BIOPHARMA INC
WAYNE 
 
SPRINGATE 
EXECUTIVE OFFICER
HEMISPHERX BIOPHARMA INC
DAVID 
 
STRAYER 
EXECUTIVE OFFICER
HEMISPHERX BIOPHARMA INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-02-21
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-02-16 
2024-02-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-02-16 
2018-04-25
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2018-04-24 
2017-02-13
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2017-02-03 
2016-09-02
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2016-08-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ASCENDIANT CAPITAL MARKETS, LLC
152912
NONE
NONE
MAXIM GROUP LLC
120708
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375